Search Results for: embryo models

ACT patent filing for MSCs: of Dancing Mice & Multiple Sclerosis

dancing-mice

Is Advanced Cell Technology (ACT) on the road to cure Multiple Sclerosis (MS) using stem cells and specifically MSCs? Some folks seem to think it’s quite possible, but I remain skeptical. Still there have been some interesting developments. ACT has a relatively new patent filing for a mesenchymal stromal cell (MSC) product that was just […]

ACT patent filing for MSCs: of Dancing Mice & Multiple Sclerosis Read More »

Interview with Gary Rabin of Advanced Cell Technology (ACT)

Gary-Rabin-headshot-formatted-5.25

One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS

Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »

iPS cell pre-clinical data should be published before starting first human clinical trials

human-IPS-cells-made-in-Knoeplfer-lab-stained-for-TRA-160

It is always exciting when a biomedical technology as revolutionary as iPS cells is on the cusp of being used in patients for the first time. In the last few days stories have reported about how a proposed clinical trial based on iPS cells has completed several regulatory steps and is closer to starting. This

iPS cell pre-clinical data should be published before starting first human clinical trials Read More »

Interview with NeoStem CEO Robin Smith Part 2: VSEL, ES cells, and iPS cells

I recently did a Q&A interview with NeoStem CEO Dr. Robin Smith. I posted Part 1 of that interview a few days ago here. Now we have part two focused on VSEL, ES cells, and iPS cells. PK: I frequently have readers of my blog ask questions about VSEL. They seem puzzled and unsure of

Interview with NeoStem CEO Robin Smith Part 2: VSEL, ES cells, and iPS cells Read More »

Why Yamanaka deserved the Nobel Prize for induced pluripotent stem cells

I believe and have argued for years that Shinya Yamanaka, the discoverer of induced pluripotent stem cells (aka iPS cells) deserves the Nobel Prize. I’m very glad today that he received it. Some readers may find it a bit ironic that I believe so strongly in this way since over the years I have often

Why Yamanaka deserved the Nobel Prize for induced pluripotent stem cells Read More »

Stem Cell Essay Contest Winner Category 2: Agnes Oshiro

Yesterday I announced the category 1 (age 18 or younger) winner of my stem cell essay contest. The fascinating topic was what do we become if we start replacing our parts with transplants. Prize? Publication and $50 iTunes gift card. Today I announce the winner of Category 2, Agnes Oshiro of Davis, CA. Congratulations, Agnes.

Stem Cell Essay Contest Winner Category 2: Agnes Oshiro Read More »

iPS cells coming into focus: not quite so similar to ESC after all

FaviconIPSCELL

Update in 2020: It seems now after all these years that the consensus in the now more mature field is that IPSCs and ESCs are nearly identical in most cases, and both have some of the same translational challenges such as teratoma-forming activity. It’s interesting to read this post from nearly 10 years ago and

iPS cells coming into focus: not quite so similar to ESC after all Read More »